These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26028320)
1. Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs. Diemberger I; Massaro G; Cubelli M; Rubino D; Quercia S; Martignani C; Ziacchi M; Biffi M; Bernardi A; Cacciari N; Zamagni C; Boriani G Eur J Clin Pharmacol; 2015 Aug; 71(8):1001-9. PubMed ID: 26028320 [TBL] [Abstract][Full Text] [Related]
2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Mayet S; Gossop M; Lintzeris N; Markides V; Strang J Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918 [TBL] [Abstract][Full Text] [Related]
3. Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review. Porta-Sánchez A; Gilbert C; Spears D; Amir E; Chan J; Nanthakumar K; Thavendiranathan P J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217664 [TBL] [Abstract][Full Text] [Related]
4. Drugs and ventricular repolarization in a general population: the Rotterdam Study. Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883 [TBL] [Abstract][Full Text] [Related]
5. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain. Madden K; Jo E; Williams JL; Liu D; Bruera E J Pain Symptom Manage; 2019 Oct; 58(4):678-684. PubMed ID: 31195079 [TBL] [Abstract][Full Text] [Related]
6. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations . Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for QTc interval prolongation. Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918 [TBL] [Abstract][Full Text] [Related]
8. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors. Abu Rmilah AA; Lin G; Begna KH; Friedman PA; Herrmann J Int J Cancer; 2020 Dec; 147(11):3160-3167. PubMed ID: 32449208 [TBL] [Abstract][Full Text] [Related]
9. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation. Milic M; Bao X; Rizos D; Liu F; Ziegler MG Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469 [TBL] [Abstract][Full Text] [Related]
10. Impact of left ventricular hypertrophy on QT prolongation and associated mortality. Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189 [TBL] [Abstract][Full Text] [Related]
11. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors. Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492 [TBL] [Abstract][Full Text] [Related]
12. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. van der Sijs H; Kowlesar R; Klootwijk AP; Nelwan SP; Vulto AG; van Gelder T Br J Clin Pharmacol; 2009 Mar; 67(3):347-54. PubMed ID: 19523015 [TBL] [Abstract][Full Text] [Related]
13. Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias. Chowdhury M; Wong J; Cheng A; Khilkin M; Palma E Cardiovasc Ther; 2015 Jun; 33(3):127-33. PubMed ID: 25825202 [TBL] [Abstract][Full Text] [Related]
14. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy. Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435 [TBL] [Abstract][Full Text] [Related]
15. Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice. Keller GA; Alvarez PA; Ponte ML; Belloso WH; Bagnes C; Sparanochia C; Gonzalez CD; Villa Etchegoyen MC; Diez RA; Di Girolamo G Curr Drug Saf; 2016; 11(1):86-98. PubMed ID: 26537523 [TBL] [Abstract][Full Text] [Related]
16. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation. Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab. Agrawal S; Waxman I; Lambert A; Roy A; Darbenzio R Cancer Chemother Pharmacol; 2016 Mar; 77(3):635-41. PubMed ID: 26861469 [TBL] [Abstract][Full Text] [Related]
19. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies. Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care-A Cause for Concern? Hardy JR; Bundock D; Cross J; Gibbons K; Pinkerton R; Kindl K; Good P; Philip J J Pain Symptom Manage; 2020 Apr; 59(4):856-863. PubMed ID: 31866486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]